The latest closing stock price for Avalo Therapeutics as of May 28, 2025 is 3.59.
An investor who bought $1,000 worth of Avalo Therapeutics stock at the IPO in 2015 would have $-1,000 today, roughly -1 times their original investment - a -55.40% compound annual growth rate over 10 years.
The all-time high Avalo Therapeutics stock closing price was 20793.60 on February 27, 2019.
The Avalo Therapeutics 52-week high stock price is 16.00, which is 345.7% above the current share price.
The Avalo Therapeutics 52-week low stock price is 3.39, which is 5.6% below the current share price.
The average Avalo Therapeutics stock price for the last 52 weeks is 8.97.
An investor who bought $1,000 worth of Avalo Therapeutics stock at the IPO in 2015 would have $-1,000 today, roughly -1 times their original investment - a -55.40% compound annual growth rate over 10 years.
The all-time high Avalo Therapeutics stock closing price was 20793.60 on February 27, 2019.
The Avalo Therapeutics 52-week high stock price is 16.00, which is 345.7% above the current share price.
The Avalo Therapeutics 52-week low stock price is 3.39, which is 5.6% below the current share price.
The average Avalo Therapeutics stock price for the last 52 weeks is 8.97.